CSI Market
Sign In | Register

Minimed Group Inc (MMED) Quarterly Income Statement

Quarterly · GAAP · USD millions
Access MMED Annual Income Statement →
Quarterly income statement trends provide context on Minimed Group Inc's margins, operating leverage, and earnings trajectory.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jul 31 2026)
Q1 2026 		(Apr 24 2026) (Jan 23 2026) (Oct 24 2025) (Jul 25 2025)
Revenues
Revenue From Contract With Customer Excluding Assessed Tax843.00
Total Revenue843.00
Costs & Expenses
Cost of Goods and Services Sold378.00
Gross Profit465.00
Selling, Administration, Marketing312.00
Depreciation & Amortization47.00
Research and Development Expense (Excluding Acquired in Process Cost)115.00
(Gain) Loss Related to Litigation Settlement2.00
Other Operating Expense / -Income-26.00
Total operating costs including COS838.00
Operating income / -loss5.00
Net Interest (-)Expense / Income0.00
Other loss / -income0.00
Total costs & expenses839.00
Income & Taxes
Income / -loss before income taxes4.00
Income taxes expenses / -benefit4.00
Income after income taxes0.00
Income / -loss from continuing operations0.00
Non-controlling interests0.00
Net income / -loss0.00
Income / -loss to shareholder0.00
EBIT4.00
EBITD45.00
EBITDA51.00
Earnings Per Share
Basic EPS (excl. extra items)0.00
Basic Net EPS0.00
Basic shares outstanding (Mill. of Units)281.00
Diluted Net EPS0.00
Diluted average shares (Mill. of Units)281.00
4 historic quarters locked

Sign in to unlock the full Minimed Group Inc income statement history.

Sign In Create Free Account

About Minimed Group Inc Quarterly Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-Q filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-Q filings
  • Filed with the SEC: September 8, 2026
  • Original filing: mdt-20260731.htm

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.